High expression of human CYP2C in immortalized human liver epithelial cells

被引:9
作者
Bort, R
Castell, JV
Pfeifer, A
Gómez-Lechón, MJ
Macé, K
机构
[1] Univ Valencia, Hosp La Fe, Unidad Hepatol Expt, Ctr Invest, E-46009 Valencia, Spain
[2] Univ Valencia, Fac Med, Dept Bioquim & Biol Mol, E-46010 Valencia, Spain
[3] Nestle Res Ctr, CH-1000 Lausanne 26, Switzerland
关键词
cytochrome P450; lipofection; expression;
D O I
10.1016/S0887-2333(99)00069-7
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Cell lints stably expressing high levels of single isozymes of human CYP2C genes (CYP2C8, CYP2C9. CYP2C18 and CYP2C19) have been successfully generated by transfecting liver epithelial human cells (THLE) with an appropriate expression vector. To this aim, cDNAs encoding for each CYP2C gene;were inserted by blunt-ended cloning into the unique insertion site of the singular expression vector pCMVneo. The recombinant pCMV2C8, pCMV2C9. pCMV2C18 and pCMV2C19 vectors were liposome-mediated transfected into THLE cells. The resulting transgenic cells, designated as T5-2C8. T5-2C9, T5-2C18 and T5-2C19, were cloned and the expression of the ectopic gene, mRNA and protein, was investigated by RT-PCR and Western blot analysis. The functionality of each expressed CYP2C was assessed by determining specific catalytic activities in these cells. that is, taxol-6-hydroxylation for CYP2C8; diclofenac-4'-hydroxylation for CYP2C9; S-mephenytoin-4'-hydroxylation for CYP2C18; S-mephenytoin-4'-hydroxylation for CYP2C19. As a result of the combined strategies used here, the transfected cells showed activities four to seven times higher than those of 24-hour cultured hepatocytes. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:633 / 638
页数:6
相关论文
共 22 条
  • [1] SUPPRESSION OF HUMAN COLORECTAL-CARCINOMA CELL-GROWTH BY WILD-TYPE-P53
    BAKER, SJ
    MARKOWITZ, S
    FEARON, ER
    WILLSON, JKV
    VOGELSTEIN, B
    [J]. SCIENCE, 1990, 249 (4971) : 912 - 915
  • [2] Bort R, 1996, DRUG METAB DISPOS, V24, P834
  • [3] HUMAN CELL-LINES, DERIVED FROM AHH-1 TK+/- HUMAN LYMPHOBLASTS, GENETICALLY-ENGINEERED FOR EXPRESSION OF CYTOCHROMES-P450
    CRESPI, CL
    LANGENBACH, R
    PENMAN, BW
    [J]. TOXICOLOGY, 1993, 82 (1-3) : 89 - 104
  • [4] deGroene EM, 1996, CANCER RES, V56, P299
  • [5] EVIDENCE THAT CYP2C19 IS THE MAJOR (S)-MEPHENYTOIN 4'-HYDROXYLASE IN HUMANS
    GOLDSTEIN, JA
    FALETTO, MB
    ROMKESSPARKS, M
    SULLIVAN, T
    KITAREEWAN, S
    RAUCY, JL
    LASKER, JM
    GHANAYEM, BI
    [J]. BIOCHEMISTRY, 1994, 33 (07) : 1743 - 1752
  • [6] GOMEZLECHON MJ, 1990, IN VITRO CELL DEV B, V26, P67
  • [7] CYTOCHROMES P450 EXPRESSION SYSTEMS
    GONZALEZ, FJ
    KORZEKWA, KR
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1995, 35 : 369 - 390
  • [8] GONZALEZ FJ, 1991, METHOD ENZYMOL, V206, P85
  • [9] CYTOCHROME-P450TB (CYP2C) - A MAJOR MONOOXYGENASE CATALYZING DICLOFENAC 4'-HYDROXYLATION IN HUMAN LIVER
    LEEMANN, T
    TRANSON, C
    DAYER, P
    [J]. LIFE SCIENCES, 1993, 52 (01) : 29 - 34
  • [10] Aflatoxin B-1-induced DNA adduct formation and p53 mutations in CYP450-expressing human liver cell lines
    Mace, K
    Aguilar, F
    Wang, JS
    Vautravers, P
    GomezLechon, M
    Gonzalez, FJ
    Groopman, J
    Harris, CC
    Pfeifer, AMA
    [J]. CARCINOGENESIS, 1997, 18 (07) : 1291 - 1297